Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 29, 2021, titled "Press Release for Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2020".
Press Release Jan 29 2021
Filed with NSE · · 3 pages · English
Summary by 6ix AI
The company reported a significant increase in revenue, with a notable contribution from Covid-related services. Normalized EBITDA and profit after tax also showed substantial growth compared to the same quarter last year. Additionally, the Board approved an interim dividend for shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Dr. Lal PathLabs Limited on 6ix
Earlier from Dr. Lal PathLabs
Later from Dr. Lal PathLabs
- Press Release May 21 2021
- Press Release Jul 30 2021
- Press Release Oct 26 2021
- Press Release Feb 10 2022
- Press Release May 17 2022
Follow Dr. Lal PathLabs into a list and get an email when it puts out news.
Follow Dr. Lal PathLabs